Exchange: NASDAQ·Updated 12:53 PM EDT
RDHL logo

RDHL RedHill Biopharma Ltd.

$1.05
$0.389
(58.85%)
Today
Mkt Cap$4.02M
Vol92.59M

About RDHL

RedHill Biopharma Ltd. engages in the development and commercialization of drugs for gastrointestinal (GI), infectious diseases, and oncology. The firm's products include Talicia, Movantik, and Aemcolo. It operates through the Commercial Operations and Research and Development segments. The Commercial Operations segment covers areas relating to commercial sales through a subsidiary in the United States. The Research and Development segment includes the study and licensing of therapeutic candidates. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.
98

Extremely Bullish Sentiment

How do you feel about RDHL?

Advertisement|Remove ads.